These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22451567)

  • 1. Using the BI-RADS lexicon in a restrictive form of double reading as a strategy for minimizing screening mammography recall rates.
    Ghate SV; Baker JA; Kim CE; Johnson KS; Walsh R; Soo MS
    AJR Am J Roentgenol; 2012 Apr; 198(4):962-70. PubMed ID: 22451567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arbitration of discrepant BI-RADS 0 recalls by a third reader at screening mammography lowers recall rate but not the cancer detection rate and sensitivity at blinded and non-blinded double reading.
    Klompenhouwer EG; Weber RJ; Voogd AC; den Heeten GJ; Strobbe LJ; Broeders MJ; Tjan-Heijnen VC; Duijm LE
    Breast; 2015 Oct; 24(5):601-7. PubMed ID: 26117723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast imaging reporting and data system standardized mammography lexicon: observer variability in lesion description.
    Baker JA; Kornguth PJ; Floyd CE
    AJR Am J Roentgenol; 1996 Apr; 166(4):773-8. PubMed ID: 8610547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.
    Lazarus E; Mainiero MB; Schepps B; Koelliker SL; Livingston LS
    Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recall rate of screening ultrasound with automated breast volumetric scanning (ABVS) in women with dense breasts: a first quarter experience.
    Arleo EK; Saleh M; Ionescu D; Drotman M; Min RJ; Hentel K
    Clin Imaging; 2014; 38(4):439-444. PubMed ID: 24768327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound.
    Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
    AJR Am J Roentgenol; 2016 Mar; 206(3):666-72. PubMed ID: 26901026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Yield and Patterns of Follow-up for BI-RADS Category 3 after Screening Mammography Recall in the National Mammography Database.
    Berg WA; Berg JM; Sickles EA; Burnside ES; Zuley ML; Rosenberg RD; Lee CS
    Radiology; 2020 Jul; 296(1):32-41. PubMed ID: 32427557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the results of mammography screening in Dubrovnik-Neretva County in the 2006-2009 period].
    Dzono-Boban A; Mratović MC; Masanović M
    Acta Med Croatica; 2010 Dec; 64(5):453-9. PubMed ID: 21692270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Level of suspicion of a mammographic lesion: use of features defined by BI-RADS lexicon and correlation with large-core breast biopsy.
    Bérubé M; Curpen B; Ugolini P; Lalonde L; Ouimet-Oliva D
    Can Assoc Radiol J; 1998 Aug; 49(4):223-8. PubMed ID: 9709675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lesion and patient characteristics associated with malignancy after a probably benign finding on community practice mammography.
    Lehman CD; Rutter CM; Eby PR; White E; Buist DS; Taplin SH
    AJR Am J Roentgenol; 2008 Feb; 190(2):511-5. PubMed ID: 18212240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.
    Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE
    Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why Start Now? Retrospective Study Evaluating Baseline Screening Mammography in Patients Age 60 and Older.
    Chieh AY; Willis JG; Carroll CM; Mobley AA; Li Y; Li M; Woodard S
    Curr Probl Diagn Radiol; 2024; 53(1):62-67. PubMed ID: 37704485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient compliance and diagnostic yield of 18-month unilateral follow-up in surveillance of probably benign mammographic lesions.
    Chung CS; Giess CS; Gombos EC; Frost EP; Yeh ED; Raza S; Birdwell RL
    AJR Am J Roentgenol; 2014 Apr; 202(4):922-7. PubMed ID: 24660725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis for the breast cancer screening among urban populations in China, 2012-2013].
    Mi ZH; Ren JS; Zhang HZ; Li J; Wang Y; Fang Y; Shi JF; Zhang K; Zhao JB; Dai M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Oct; 50(10):887-892. PubMed ID: 27686767
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcomes of unconventional utilization of BI-RADS category 3 assessment at opportunistic screening.
    Altas H; Tureli D; Cengic I; Kucukkaya F; Aribal E; Kaya H
    Acta Radiol; 2016 Nov; 57(11):1304-1309. PubMed ID: 26019241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the American College of Radiology BI-RADS guidelines by community radiologists: concordance of assessments and recommendations assigned to screening mammograms.
    Lehman C; Holt S; Peacock S; White E; Urban N
    AJR Am J Roentgenol; 2002 Jul; 179(1):15-20. PubMed ID: 12076896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast imaging reporting and data system lexicon for US: interobserver agreement for assessment of breast masses.
    Abdullah N; Mesurolle B; El-Khoury M; Kao E
    Radiology; 2009 Sep; 252(3):665-72. PubMed ID: 19567644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories.
    Liberman L; Abramson AF; Squires FB; Glassman JR; Morris EA; Dershaw DD
    AJR Am J Roentgenol; 1998 Jul; 171(1):35-40. PubMed ID: 9648759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The added value of an artificial intelligence system in assisting radiologists on indeterminate BI-RADS 0 mammograms.
    Yi C; Tang Y; Ouyang R; Zhang Y; Cao Z; Yang Z; Wu S; Han M; Xiao J; Chang P; Ma J
    Eur Radiol; 2022 Mar; 32(3):1528-1537. PubMed ID: 34528107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The application value of BI-RADS lexicon and high-frequency CDFI scoring in differentiation of benign from malignant lesions of the breast].
    Yang M; Liu F; Gu XN; Cai YL; Wang YY; Zhou WJ
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(23):1833-5. PubMed ID: 24124721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.